Qiagen N.V. (FRA:QIA)
Germany flag Germany · Delayed Price · Currency is EUR
37.17
-0.27 (-0.71%)
Last updated: May 9, 2025

Qiagen Company Description

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories.

It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing.

The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions.

It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services.

The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers.

The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Qiagen N.V.
Country Netherlands
Founded 1984
Industry Laboratory Analytical Instruments
Employees 5,396
CEO Thierry Bernard

Contact Details

Address:
Hulsterweg 82
Venlo, 5912 PL
Netherlands
Phone 31 77 355 6600
Website qiagen.com

Stock Details

Ticker Symbol QIA
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency USD
SIC Code 3826

Key Executives

Name Position
Thierry Bernard Chief Executive Officer
Roland Sackers Chief Financial Officer
Antonio Santos Chief Operating Officer
John Gilardi Head of Investor Relations